Clinical trial
Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer…
NCT00123799 · AHS Cancer Control Alberta, Other · Terminated
Key facts
| NCT number | NCT00123799 |
|---|---|
| Title | Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection |
| Official title | A Phase II Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Procedure |
| Interventions | Positron Emission Tomography Imaging |
| Enrollment | 199 |
| Start date | Jun 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Jul 26, 2005 |
| Last update posted | Jun 21, 2024 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: